Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3633-3639

  Schaefer, Betti ^a   Schaefer, Franz ^a   Engelmann, Guido ^a   Meyburg, Jochen ^a   Heckert, Karl Heinz ^a   Zorn, Markus ^a   Schmitt, Claus Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

children; haemodialysis; liver failure; molecular adsorbents recirculating system; plasma exchange

Indexed keywords

AMMONIA; BILIRUBIN;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; ALBUMIN DIALYSIS; AMMONIA BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; HEMODIALYSIS; HUMAN; INFANT; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LIVER FAILURE, ACUTE; MALE; PLASMA EXCHANGE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SORPTION DETOXIFICATION; YOUNG ADULT;

EID: 80155171994     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr115     Document Type: Article

References (50)

1. Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care 2007; 23: 129-135
2. Stravitz RT, Kramer DJ. Medscape. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-553
3. Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom. J Pediatr Gastroenterol Nutr 2005; 40: 575-581
4. Jalan R, Sen S, Steiner C et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003; 38: 24-31
5. Sorkine P, Ben Abraham R, Szold O et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29: 1332-1336
6. Schmidt LE, Svendsen LB, Sørensen VR et al. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 2001; 7: 709-712
7. Schmidt LE, Wang LP, Hansen BA et al. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003; 9: 290-297
8. Mitzner SR, Klammt S, Peszynski P et al. Improvement ofmultiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001; 5: 417-422
9. Parés A, Cisneros L, Salmerón JM et al. Extracorporeal albumin dialysis: A procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 1105-1110
10. Bellmann R, Graziadei IW, Feistritzer C et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10: 107-114
11. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: Analysis of 176 patients of the International MARS Registry. Liver 2002; 22: 20-25
12. Stange J, Mitzner SR, Risler T et al. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319-330
13. Mitzner SR, Stange J, Klammt S et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-286
14. Heemann U, Treichel U, Loock J et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002; 36: 949-958
15. Sen S, Davies NA, Mookerjee RP et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study. Liver Transpl 2004; 10: 1109-1119
16. Hassanein TI, Tofteng F, Brown RS Jr et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46: 1853-1862
17. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: A meta-analysis. Liver Transpl 2004; 10: 1099-1106
18. Laleman W, Wilmer A, Evenepoel P et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-onchronic alcoholic liver failure. Crit Care 2006; 10: R108
19. Dethloff T, Tofteng F, Frederiksen HJ et al. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: A randomized controlled study. World J Gastroenterol 2008; 14: 2065-2071
20. Krisper P, Haditsch B, Stauber R et al. In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451-457
21. Meijers BK, Verhamme P, Nevens F et al. Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant 2007; 7: 2195-2199
22. Faybik P, Bacher A, Kozek-Langenecker SA et al. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: An observational study. Crit Care 2006; 10: R24
23. Bachli EB, Schuepbach RA, Maggiorini M et al. Artificial liver support with the molecular adsorbent recirculating system: Activation of coagulation and bleeding complications. Liver Int 2007; 27: 475-484
24. Doria C, Mandalá L, Smith JD et al. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004; 18: 365-371
25. Singer AL, Olthoff KM, Kim H et al. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001; 234: 418-424
26. Larsen FS, Hansen BA, Jørgensen LG et al. Cerebral blood flow velocity during high volume plasmapheresis in fulminant hepatic failure. Int J Artif Organs 1994; 17: 353-361
27. Clemmesen JO, Larsen FS, Ejlersen E et al. Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol 1997; 9: 55-60
28. Nadalin S, Heuer M, Wallot M et al. Paediatric acute liver failure and transplantation. the University of Essen experience. Transpl Int 2007; 20: 519-527
29. Novelli G, Rossi M, Morabito V et al. Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc 2008; 40: 1921-1924
30. Tissiéres P, Sasbón JS, Devictor D. Liver support for fulminant hepatic failure: Is it time to use the molecular adsorbents recycling system in children? Pediatr Crit Care Med 2005; 6: 585-591
31. Da Costa M, Lee MK, Lee HL et al. MARS liver dialysis in children with acute liver failure. Ann Acad Med Singapore 2004; 33: 73-74
32. Markiewicz-Kijewska M, Szymczak M, Ismail H et al. Liver transplantation for fulminant Wilson's disease in children. Ann Transplant 2008; 13: 28-31
33. Prokurat S, Grenda R, Lipowski D et al. MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium- copper acute intoxication: A paediatric case report. Liver 2002; 22: 76-77
34. Ozdemir FN, Tutal E, Sezer S et al. Effect of supportive extracorporeal treatment in liver transplantation recipients and advanced liver failure patients. Hemodial Int 2006; 10: 28-32
35. Nakae H, Yonekawa C, Wada H et al. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure. Ther Apher 2001; 5: 471-475
36. Arbeiter AK, Kranz B, Wingen AM et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant 2010; 25: 1257-1265
37. Schaefer F, Straube E, Oh J et al. Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 1999; 14: 910-918
38. Covic A, Goldsmith DJ, Gusbeth-Tatomir P et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003; 23: 21-27
39. Gong D, Cruz D, Ronco C. Depurative capacity of molecular adsorbent recycling system (MARS): A focus on bilirubin removal. Int J Artif Organs 2008; 31: 875-881
40. Patzer J. Principles of bound solute dialysis. Ther Apher Dial 2006; 10: 118-124
41. Steiner C, Sen S, Stange J et al. Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management. Liver Transpl 2004; 10: 1531-1538
42. Gong D, Ji D, Ren B et al. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Int J Artif Organs 2008; 31: 333-339
43. Klammt S, Mitzner SR, Stange J et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl 2008; 14: 1333-1339
44. Auth MK, Kim HS, Beste M et al. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 2005; 40: 54-59
45. Di Campli C, Zocco MA, Gaspari R et al. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 2005; 37: 2551-2553
46. Novelli G, Annesini MC, Morabito V et al. Cytokine level modifications: Molecular adsorbent recirculating system versus standard medical therapy. Transplant Proc 2009; 41: 1243-1248
47. Klammt S, Koball S, Hickstein H et al. Increase of octanoate concentrations during extracorporeal albumin dialysis treatments. Ther Apher Dial 2009; 13: 437-443
48. Akdogan M, Camci C, Gurakar A et al. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher 2006; 21: 96-99
49. Rivera-Penera T, Moreno J, Skaff C et al. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr 1997; 24: 128-134
50. Kantola T, Koivusalo AM, Parmanen S et al. Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol 2009; 15: 3015-3024